How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy

Expert Rev Anticancer Ther. 2024 Apr 16. doi: 10.1080/14737140.2024.2344650. Online ahead of print.NO ABSTRACTPMID:38626305 | DOI:10.1080/14737140.2024.2344650

Source: Expert Review of Anticancer Therapy - April 16, 2024 Category: Cancer & Oncology Authors: James A Davis Mary McGann Jessica Marini Hamza Hashmi Source Type: research